Get informed when a big investor buys or sells
+ FollowUndervalued by 122.2% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $3.82 Billion |
|---|---|
| Enterprise Value | $-120,998,335,320.00 |
| Annual dividend | $0.49 |
| Dividend yield | 2.42% |
| Earnings per Share | $207.71 |
| Beta | -0.02 |
| Outstanding Shares | 204,698,000 |
| P/E Ratio | 15.2 |
|---|---|
| PEG | -57.88 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | -0.03 |
| Enterprise Value to EBIT | -1.96 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | -1.19 |
| Debt to Equity | 0.23 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, ...